文献速递神经肿瘤

垂体腺瘤术后第1和第2天晨皮质醇预测长期继发性肾上腺皮质功能不全

Postoperative days 1 and 2 morning cortisol levels as predictors of long-term secondary adrenal insufficiency following pituitary adenoma surgery.
PubMed 文献 · J Neurosurg · 2026-02-06

本研究纳入229例垂体腺瘤切除术患者,评估术后第1天(POD1)和第2天(POD2)晨血清皮质醇对术后新发继发性肾上腺皮质功能不全(SAI)及其他内分泌结局的预测价值。结果显示POD2晨皮质醇预测任何SAI的AUC为0.990,优于POD1的0.719, cutoff值4.95 µg/dL时灵敏度100%、特异度96.1%。

要点

  • POD2晨皮质醇预测新发SAI的AUC为0.990,优于POD1的0.719。
  • POD1晨皮质醇每增加1 µg/dL,发生任何SAI的 odds 降低9%。
  • POD2晨皮质醇 cutoff 4.95 µg/dL 预测SAI灵敏度100%、特异度96.1%。

核心结论

  • POD2晨皮质醇是新发术后SAI更特异的预测指标,且对其他长期内分泌疾病有预测效用。

研究设计与样本

  • 回顾性研究纳入2012年6月至2023年8月接受垂体腺瘤切除术、有POD1或POD2晨血清皮质醇结果且术后内分泌随访至少1年的患者。
  • 排除既往库欣综合征或围手术期接受类固醇的患者,共229例(137例女性,平均年龄51.4岁)。

主要发现

  • 17.0%新发低促性腺激素性性腺功能减退,13.0%新发中枢性甲状腺功能减退,3.9%精氨酸加压素缺乏,3.0%生长激素缺乏。
  • 任何SAI的发生与POD1晨皮质醇(OR 0.91,95% CI 0.86-0.97;p=0.004)和POD2晨皮质醇(OR 0.30,95% CI 0.09-0.96;p=0.041)均显著相关。
  • POD2晨皮质醇预测任何SAI的AUC为0.990(p<0.001),cutoff值4.95 µg/dL,灵敏度100%、特异度96.1%;POD1的AUC为0.719。
  • POD1晨皮质醇每增加1 µg/dL,发生任何SAI的 odds 降低9%;POD2晨皮质醇每增加1 µg/dL, odds 降低70%。

关键数值与推荐

  • POD2晨皮质醇 cutoff 4.95 µg/dL 预测任何SAI:灵敏度100%,特异度96.1%,AUC 0.990。
  • POD1晨皮质醇 OR 0.91(95% CI 0.86-0.97;p=0.004);POD2晨皮质醇 OR 0.30(95% CI 0.09-0.96;p=0.041)。

临床怎么用

  • 术后第2天晨皮质醇可用于预测垂体腺瘤切除术后新发SAI,cutoff 4.95 µg/dL时灵敏度和特异度高。
  • POD1和POD2晨皮质醇均可提供预测信息,但POD2对SAI的特异性更优。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Secondary adrenal insufficiency (SAI) is an uncommon sequela following resection of pituitary adenoma. The aim of this study was to evaluate the utility of postoperative days (PODs) 1 and 2 morning cortisol levels for predicting the development of new SAI and other endocrine outcomes following pituitary adenoma resection. METHODS: Patients who underwent resection of pituitary adenoma (June 2012-August 2023) with available POD1 or POD2 morning serum cortisol levels and a minimum postoperative endocrine follow-up of 1 year were included. Patients were excluded if they had preexisting Cushing's syndrome or received steroids perioperatively. Logistic regression and receiver operating characteristic analyses were conducted to assess the performance of POD1 and POD2 morning cortisol levels for prediction of new postoperative SAI and other long-term endocrine outcomes, with optimal cutoff values determined using Youden's index. RESULTS: Of 229 patients (137 female, mean age 51.4 years), 219 (95.6%) had available POD1 morning cortisol results, 59 (25.7%) had POD2 results, and 49 (21.4%) had both POD1 and POD2 results. Eighteen patients (7.8%) developed new SAI postoperatively. Over long-term follow-up, 6.1% of patients had long-term SAI, 24.8% had persistent new hypopituitarism in one or more pituitary axes, 17.0% had new hypogonadotropic hypogonadism, 13.0% had new central hypothyroidism, 3.9% had arginine vasopressin deficiency, and 3.0% had growth hormone deficiency. The development of any SAI was significantly associated with both POD1 (OR 0.91, 95% CI 0.86-0.97; p = 0.004) and POD2 (OR 0.30, 95% CI 0.09-0.96; p = 0.041) morning cortisol levels, with POD2 levels having superior discriminative performance (POD1: area under the receiver operating characteristic curve [AUC] 0.719 vs POD2: AUC 0.990). POD2 morning cortisol significantly predicted development of any SAI (AUC 0.990, p < 0.001) with a cutoff of 4.95 µg/dL (sensitivity of 100% and specificity of 96.1%). Logistic regression revealed that each 1-µg/dL increase in POD1 morning cortisol was associated with reduced odds of developing any SAI by 9% (OR 0.91, 95% CI 0.86-0.97; p = 0.004). In those who underwent POD2 cortisol testing, each 1-µg/dL increase in the POD2 morning cortisol level was associated with reduced odds of developing any SAI by 70% (OR 0.30, 95% CI 0.09-0.96; p = 0.041). CONCLUSIONS: Although cortisol assessment on both POD1 and POD2 was useful following pituitary adenoma resection, the POD2 morning cortisol level was a more specific predictor of new postoperative SAI while also having predictive utility for other long-term endocrinopathies.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Liu KG, Gomez D, Shah I, et al. Postoperative days 1 and 2 morning cortisol levels as predictors of long-term secondary adrenal insufficiency following pituitary adenoma surgery. J Neurosurg. 2026. PMID: 41650448. doi:10.3171/2025.9.JNS251261

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。